{'fraction_non_alphanumeric': 0.030332329622365258, 'fraction_numerical': 0.019171800325975857, 'mean_word_length': 5.4596716630977875, 'pattern_counts': {'":': 0, '<': 10, '<?xml version=': 0, '>': 3, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Provisional Decision-Making for Perioperative Blood Pressure Management: A Narrative Review

Blood pressure (BP) is a basic determinant for organ blood flow supply. Insufficient blood supply will cause tissue hypoxia, provoke cellular oxidative stress, and to some extent lead to organ injury. Perioperative BP is labile and dynamic, and intraoperative hypotension is common. It is unclear whether there is a causal relationship between intraoperative hypotension and organ injury. However, hypotension surely compromises perfusion and causes harm to some extent. Because the harm threshold remains unknown, various guidelines for intraoperative BP management have been proposed. With the pending definitions from robust randomized trials, it is reasonable to consider observational analyses suggesting that mean arterial pressures below 65 mmHg sustained for more than 15 minutes are associated with myocardial and renal injury. Advances in machine learning and artificial intelligence may facilitate the management of hemodynamics globally, including fluid administration, rather than BP alone. The previous mounting studies concentrated on associations between BP targets and adverse complications, whereas few studies were concerned about how to treat and multiple factors for decision-making. Hence, in this narrative review, we discussed the way of BP measurement and current knowledge about baseline BP extracting for surgical patients, highlighted the decision-making process for BP management with a view to providing pragmatic guidance for BP treatment in the clinical settings, and evaluated the merits of an automated blood control system in predicting hypotension.


Introduction
Approximately 300 million surgical operations are conducted globally every year [1,2], with most of the concerned patients being at risk of perioperative hemodynamic instability. The American College of Cardiology/American Heart Association (ACC/AHA) updated its guidelines for blood pressure (BP) management in patients with chronic hypertension in 2017, and the European Society of Cardiology/ European Society of Hypertension updated its guidelines in 2018 [3,4]. However, these guidelines are not fully applicable to perioperative patients because of the dynamic nature of the patients' physiological status, characterized by increased stress and immune response, inflammation, hypercoagulable state, and pain [5][6][7][8]. For long, anesthesiologists have been taught and believed that perioperative BP should be maintained within ±20% of the baseline values in practice; however, this recommendation is not evidence-based. Consequently, BP management varies considerably among clinicians. To provide pragmatic guidance and highlight the importance of optimizing BP perioperatively, this manuscript is a review of recent research on perioperative BP management, especially those on the targets and decision-making process.

The Physiology of BP and Organ Perfusion
BP is one of the routinely measured variables in the perioperative period; it is the force that propels blood to the tissues and organs. BP is the interplay between cardiac output or stroke volume and systemic vascular resistance at a given filling pressure, which is affected by various hemodynamic elements [5] such as intravascular volume, myocardial contractility, cardiac compliance, heart rate, and vascular radius ( Figure 1). A change in one or more of these elements will not necessarily cause a change in BP. Besides, biological rhythms, hormones, and emotional states can also affect BP [9,10]. BP is an important determinant for organ blood flow supply. Insufficient blood supply causes tissue hypoxia, provokes cellular oxidative stress, and leads to organ injury and even dysfunction to some extent. The BP levels that trigger cellular oxidative stress or tissue injury vary with organs. Therefore, the underlying pathophysiological mechanisms of hypotension or hypertension may be individualized and have different influences on organ perfusion.
Pressure autoregulation is a self-regulation mechanism of an organ to maintain stable perfusion amidst fluctuations in BP or perfusion pressure [11]. When BP fluctuates violently and exceeds the pressure autoregulation threshold, the organs get into a hypo/hyperperfusable state. Of course, the autoregulation ability varies with organs, a feature known as heterogeneity. Vital organs (the brain, heart, kidneys, and spinal cord) have robust pressure autoregulation mechanisms. In contrast, the visceral organs, such as the stomach, small intestines, and colon, have weaker pressure autoregulation mechanisms, which bear the brunt when BP fluctuates violently [12]. Besides, pressure autoregulation is also influenced by intraindividual heterogeneity factors including age, chronic or acute disease, anesthesia, and sympathetic tone [12]. For example, the lower threshold of cerebral perfusion pressure in healthy participants varies from a mean arterial pressure (MAP) of 53 to 113 mmHg, with a gap of up to 60 mmHg [13].
Organ perfusion is regulated by perfusion pressure and organ-specific resistance. Perfusion pressure is determined by the gradient between the upstream pressure and downstream pressure (Figure 1). MAP decreases progressively from central to peripheral arteries given the relatively low resistance of the arterial system. Hence, MAP is a reference for organ input pressure [5]. Organ perfusion depends on BP via pressure autoregulation and the cardiac output among organs, since the total perfusion shared by all organs is equal to the cardiac output [14]. Decreased cardiac output results in blood flow redistribution to different organs, with vital organs being prioritized [15]. In a previous study, this kind of blood flow redistribution was examined in cardiac surgery; it was observed that compared to a low MAP (40-50 mmHg), a higher MAP (70-80 mmHg) did not significantly decrease the severity of brain infarcts diagnosed postoperatively [16]. This is explained by the fact that the same laminal pump flow of 2.4 L min -1 2009m -2 , which provides the same cardiac output, was used for both groups. Even though the BP was much lower in the low MAP group, the perfusion of the brain was well guaranteed. In contrast, the BP was maintained within the normal range in the perioperative period by surgical stress or vasopressor infusion, which may mask insufficient organ perfusion due to decreased cardiac output. Therefore, the goal of perioperative BP management is to optimize adequate blood flow supply, not just to concentrate on the BP values.

Perioperative BP Monitoring and Baseline BP
Appropriate BP monitoring is a prerequisite for obtaining accurate BP values and providing reliable guidance for perioperative BP management. The two most used methods for BP monitoring are intermittent oscillometric manometry with a noninvasive cuff and continuous intra-arterial invasive catheterization; however, cuffless BP measurement is an emergent popular field due to the clinical need and technology advances [17,18]. Intraoperative BP is measured using intermittent oscillometric manometry [19], which allows automatic, intermittent BP measurement, usually at 3-5 min intervals. The measurement accuracy depends on the selection of a suitable cuff  Figure 1: The physiology of BP and miscellaneous factors affecting organ perfusion. BP is determined by production of CO and SVR. PA: blood flow redistribution and organ-specific RVR influence the organ perfusion. BP: blood pressure; CO: cardiac output; SV: stroke volume; SVR: systemic vascular resistance; PA: pressure autoregulation; RVR: regional vascular resistance. 2 Oxidative Medicine and Cellular Longevity that matches the circumference of the patients' biceps, patients' posture and ambient temperature, etc. Continuous intra-arterial invasive manometry is performed using intraperipheral arterial cannula placement, which allows for continuous, real-time, and accurate BP measurement. Conventionally, it is believed that the accuracy of BP measured invasively is more than that measured with cuffs, and invasive BP measurements are often regarded as the reference method due to cuff pressure shows large limits of agreement compared to invasive BP [20]. However, there may be differences between noninvasive cuff pressure and invasive arterial pressure in different situations. In a study by Wax et al. [21] involving 24225 patients, the BP of 63% of the patients were measured both noninvasively (cuff BP) and invasively (radial artery BP), while that of 37% was measured only invasively (radial artery BP). They observed that in patients with hypotension, particularly those with an arterial systolic BP below 111 mmHg, the noninvasive cuff BP was higher than the invasive arterial pressure in most cases. However, in the patients with hypertension, the invasive measurements were higher than the noninvasive cuff pressure in most cases, especially the systolic BP values [22]. This is mainly because of the amplification of the pulse pressure difference as the pulse wave propagates from the aorta to the peripheral arteries [23], especially in patients with chronic hypertension. In patients receiving vasopressors, such as patients with sepsis [24], liver transplantation [25], and cardiac surgery under extracorporeal circulation [26], BP measured by invasive manometry is often lower than the central BP. In clinical settings, the noninvasive cuff pressure should be measured simultaneously when there is a significant difference between the two values, especially when the invasive BP is significantly low. Because the noninvasive cuff pressure is closer to the actual BP, it should be the basis for relevant management measures [27]. When encountering this condition, the merits of invasive BP should not be ignored and should be considered supplement for BP treatment.
In addition to accurate BP monitoring, obtaining a reliable and true baseline BP might be critical for BP titration and decision-making. As for the definition of baseline BP, it lacks standard definition and also varies with studies. Several studies [28][29][30][31] on the relationship between intraoperative hypotension (IOH) and BP-related complications reported that the BP value obtained before anesthesia induction should be considered the baseline BP; however, this definition is debatable and vague. Saugel et al. [9] selected patients under general anesthesia aged 40-65 years undergoing elective noncardiac surgery as the study population; they compared preoperative 24 h ambulatory BP with preanesthesia induction, postanesthesia induction BP, and intraoperative MAP. They observed that the correlation between the first BP value obtained before anesthesia induction and preoperative ambulatory MAP was poor (r = 0:429), which suggested that BP before anesthesia induction cannot be regarded as the baseline BP. To obtain an accurate baseline BP, Ard et al. [32] conducted a prospective and observational trial involving 2087 patients and measured the BP in three locations (surgical visiting clinic, unit for preoperative punctuality, and the first BP at the operating theatre). They observed that the BP obtained in the theatre was markedly higher (P < 0:01 for all comparisons), specifically systolic BP (138 ± 23 mmHg), diastolic BP (77 ± 14 mmHg), and MAP (97 ± 14 mmHg), whereas no difference was observed between the first two measurements with 128 ± 17 mmHg and 74 ± 11 mmHg and 124 ± 18 mmHg, 73 ± 11 mmHg, and 92 ± 12 mmHg, respectively. Consequently, they concluded that the BP before anesthesia induction could not be used as the baseline BP, while the BP measured in the preoperative holding area could be used as the baseline BP. Hu et al. had consistent findings with theirs [33]: the BP measured at the holding area before surgery was considered the baseline BP, and there was an association between baseline MAP and acute kidney injury (AKI) in patients after cardiac surgery, implying that this baseline BP could be used as an important predicting factor for AKI. To ascertain whether baseline BP obtained at different time points can optimize intraoperative brain function, Drummond et al. [34] defined the baseline BP as the average of three or more ambulatory clinic BP values 7 months earlier and compared them to the first BP measured in the operating cabinet in a retrospective study. They observed that if the first BP measured in the operating theatre was suggestive of hypertension, the BP was greater than ambulatory clinic recordings 7 months earlier. Furthermore, if the first BP was consistent with normotension, the BP reflected the baseline BP. Based on the previous literatures, a widely accepted protocol to determine awake baseline BP is to take BP measurement 3 to 5 times in the ward or visiting clinic after resting 5 to 10 minutes in a quiet and comfortable site, and the average of all readings can be regarded as baseline BP [35,36].
Currently, it is hypothesized that the preoperative 24 h ambulatory BP is the best reflection of the daily BP, which can be used as the baseline BP [5]. However, performing 24 h ambulatory BP monitoring preoperatively for each surgical patient to obtain the baseline BP is not practical. Therefore, further research is needed to determine a clinically practical and easy method for determining baseline BP.

The Importance of Preoperative BP Optimization
Preoperative hypertension increases the risk of perioperative adverse events. The ACC/AHA guidelines recommend postponing any elective surgery for a patient with a preoperative BP above 180/110 mmHg [3,4]. However, a previous study [37] revealed that there is no relationship between BP > 180/110 mmHg and perioperative adverse events. Moreover, there is no clear evidence that the delay in performing the surgery will improve perioperative outcomes. This is because for a timely surgery the BP should be titrated to the ideal level within a short preoperative time if it was delayed. Moreover, the rapid control of BP with medications increases the risk of postoperative complications, especially in patients with significantly elevated 3 Oxidative Medicine and Cellular Longevity preoperative BP [38]. Consequently, Howell et al. [37] reported that surgery should not be delayed because of isolated elevated preoperative BP values only in a healthy patient. Certainly, a goal of ±20% baseline BP during surgery should be kept, and measures should be taken to ensure a stable cardiovascular system intraoperatively. On the other hand, the importance of preoperative BP optimization in patients with hypertension should not be ignored.
Commonly used antihypertensive agents include angiotensin-converting enzyme inhibitors, angiotensin receptor inhibitors, β-blockers, and calcium channel blockers. Studies have observed that angiotensinconverting enzyme inhibitors and angiotensin receptor inhibitors often complicate protracted IOH [39] and may increase the incidence of perioperative AKI, stroke, myocardial injury, and mortality [40]. Therefore, the Canadian Cardiovascular Society, the European Cardiovascular Society, and the European Society of Anesthesiologists recommend the discontinuation of both drugs on the day of surgery [4,41,42]. Patients with chronic β-blocker intake, especially those with congestive heart failure or recent myocardial infarction, can continue during the perioperative period [43,44]. However, β-blockers may be deleterious in the perioperative period, as their intake is characterized by frequent hypotension and end-organ hypoperfusion. The 2008 PeriOperative ISchemic Evaluation (POISE) trial found that although preoperative initiation of β-blockers reduced the risk of nonfatal myocardial infarction, it increased the risk of cardiovascular adverse events (including bradycardia, stroke, and hypotension) and mortality in the perioperative period [45]. This finding was consistent with the results of a large retrospective cohort study, which showed that continuing β-blockers increased the 30-day mortality after surgery in elderly patients with hypertension having elevated systolic BP [46]. While Kertai et al. [47] found that although withdrawal of β-blockers reduced the need of vasopressor and shortened stay in the postanesthesia care unit, it increased risk for mortality within 48 hours after noncardiac surgery. Over the past 30 years, multiple studies have concerned about the best strategy for the perioperative approach to patients receiving β-blockers. Due to the use of β-blockers are not limited perioperatively, whether withholding or continuing and timing is still a debate and needs further study [48].
Preoperative hypotension also increases the risk of postoperative adverse events. Venkatesan et al. [7] found that preoperative systolic BP < 119 mmHg and diastolic BP < 63 mmHg were associated with increased 30-day mortality in elderly patients undergoing elective noncardiac surgery, lower preoperative BP, and higher postoperative mortality. Preoperative hypotension increases the incidence of IOH, decreases coronary perfusion pressure, and shifts the autoregulation curve to the left, which leads to ischemia of vital organs. Preoperative hypertension or hypotension in patients awaiting surgery should be normalized preoperatively, and aggressive BP management is needed to reduce or avoid adverse events.

Intraoperative BP Control Target and Its Implications
Hypotension is common during the operative period. However, the definition of IOH remains controversial. Bijker et al. [49] identified 140 definitions of IOH after a review of 130 articles. The most used definition of IOH was as follows: a decrease in the systolic BP of more than 20% from the baseline BP or a MAP < 65 mmHg [50,51]. The latter, also known as absolute thresholds, is used more frequently for the following reasons: (1) baseline BP measurements are often unknown, and approximately onethird of patients do not have a baseline BP value preoperatively, as described by Monk et al. [28]; (2) relative thresholds are not superior to absolute thresholds in predicting unfavorable outcomes as reported by Salmasi et al. [52] in a large-sample retrospective cohort analysis; (3) absolute thresholds are concrete and easier to use in decision-making; and (4) preoperative BP measurements are often elevated due to tension and anxiety. Therefore, in daily practice, absolute thresholds are adopted frequently as the baseline for BP regulation. IOH may lead to inadequate blood supply and various degrees of organ dysfunction. Several studies [16,28, found that IOH was associated with postoperative detrimental outcomes (such as AKI, myocardial injury, and neurocognitive disorders), which is related to the duration and magnitude of hypotension [77], suggesting that IOH should be avoided perioperatively (Table 1). Based on existing evidence [51,56,58,74,75], intraoperative MAP should be maintained above 65 mmHg in normal adult patients, and in patients with other comorbidities (for example, coronary artery disease and carotid stenosis), the intraoperative MAP must be individualized based on the patient's pathophysiology and clinical situation. For example, the MAP of patients with chronic hypertension should be maintained above 70 mmHg. Of note, the advocation of absolute thresholds in BP management does not mean that one-size-fits-all methods should be used. Conversely, it will lead to hypoperfusion. For instance, in chronic hypertension cases, the autoregulatory mechanisms of the kidneys are likely compromised [78], with a right shift of the threshold [79,80]. Therefore, higher MAP values should be maintained to ensure sufficient blood flow. A combination of absolute thresholds in BP management and individualized BP tailoring should be implemented for patients with comorbidities.

Postoperative BP Management
Postoperative BP is a basic component of the perioperative period, and its appropriate management is essential for a smooth postoperative recovery. Postoperative hypotension (POH) management is an important component of postoperative BP management [81].
Considering the controversy in POH, the incidence of POH varies considerably (from 8%-48%) when based on different MAP thresholds of 60-75 mmHg [82]. The secondary analysis from the POISE-2 trial [54] showed that the incidence of POH was 7.6% in the first four postoperative 4 Oxidative Medicine and Cellular Longevity      [40,82,83] and infarction [54]. To the best of our knowledge, the optimal postoperative BP target and BP threshold that leads to organ injury remains unclear [84]. Besides, duration of POH > 10 min is associated with increased risk of postoperative myocardial infarction and 30-day mortality in elderly patients. Furthermore, longer duration and greater magnitude of hypotension (systolic BP < 90 mmHg) significantly increase the risk of myocardial injury [54]. Similarly, Mohammed et al. [85] and Kause et al. [86] also observed that systolic BP < 90 mmHg was associated with postoperative emergency events in the general ward. Based on existing literature [82,87,88], POH is an independent surrogate predictor for postoperative myocardial injury, and avoiding POH helps to attenuate myocardial injury.
Whether there are causal interactions between POH and IOH is unclear. To ascertain the severity of IOH on the occurrence of POH and outcomes, a study involving 2833 patients who were transferred to the surgical intensive care unit postoperatively was conducted to investigate whether there is an association between hypotension and cardiovascular incidents or death within seven postoperative days; there was a strong association between POH and IOH severity, especially the lowest intraoperative MAP [89]. Contrarily, a retrospective study conducted in 2008-2017 and involving 67968 patients (with POH and not IOH) undergoing noncardiac surgery was conducted to assess the relationship between major adverse cardiovascular or cerebrovascular events within 30 postoperative days [90]; it was revealed that in the patients without IOH, POH was not associated with major adverse cardiovascular or cerebrovascular events at any MAP threshold (≤75, ≤65, and ≤55 mmHg). Therefore, they suggested that there was no interaction between POH and IOH. Notably, due to the inherent study limitations and the few patients with a MAP below 55 mmHg, the applicability of the conclusion in clinical practice is limited. Further studies are necessary to assess the interactions between POH and IOH.
Timely detection and prompt intervention is essential in POH correction. In the general ward, unlike the conditions in the operating theatre, monitoring of vital signs is usually intermittent with 30 min to 4-6 h intervals. Therefore, POH is often ignored or undetected during the monitoring; approximately 50% of the patients with POH are not identified, and if they are identified, it implies that the POH has been ongoing for a long time [91]. Given this situation, there is a growing interest in continuous monitoring of patients postoperatively in the general ward, which allows earlier detection of POH and thus prompt treatment, improved patient outcomes, and fewer resuscitation events, especially for high-risk patients [92][93][94]. Besides, stopping antihypertensive medication preoperatively favors postoperative BP management. When and how to initiate antihypertension agents should be weighted based on risks and benefits [41,42,84].

Individualized Hemodynamic Management in Perioperative Care Is Promising
In the past decades, BP thresholds from popular studies were used as therapeutic targets for perioperative BP management. A BP management strategy using one-size-fits-all principles does not represent an accurate personalized BP threshold for organ perfusion and oxygen supply. The current ACC/AHA guidelines [44] recommend individualized care for noncardiac surgical patients with associated comorbidities.
With the rapid advances in medical science and improved disease knowledge, perioperative individualized BP management is attracting clinical attention [73,[95][96][97]. Perioperative individualized BP management could be defined as intraoperative BP target values based on each patient's physiological and surgical characteristics, while considering acute and chronic pathophysiological cardiovascular alterations [98].
In 2017, a randomized clinical trial involving 678 elderly patients with hypertension who underwent major gastrointestinal operations were enrolled into three MAP groups (65-79, 80-95, and 96-110 mmHg) receiving intraoperative goal-directed fluid therapy (stroke volume variation: 8%-13%). Also, four vasopressor agents were used to titrate BPs within the target range. This suggested that a MAP level of 80-95 mmHg markedly lowers the possibility of postoperative AKI [69]. Intriguingly, an intermediate MAP is conducive for postoperative renal function recovery, although the authors assigned the patients to three preset MAP groups arbitrarily, suggesting that strict BP control is beneficial for organ functioning in patients with a normal BP range. Similarly, in a multicenter randomized study, 322 elderly patients were assigned to two groups based on intraoperative MAP levels (60-70 or 90-100 mmHg), and the results concluded that a high MAP significantly reduces the occurrence of postoperative delirium [66]. In nonsurgical patients, the BP management strategy affects cognitive function, and a good control for hypertension reduces the risk of cognitive impairment. In this regard, patients with Alzheimer's disease were randomly allocated into standard BP control (systolic BP goal < 120 mmHg) or intensive BP control (systolic BP goal < 140 mmHg) groups; the latter was associated with a mild and significant decrease in cerebral volume [99]. This might be the robust evidence supporting the fact that BP control and intensive BP may influence cerebral volume better than standard care in patients with hypertension.
Individualized BP control considering baseline BP might meet the demands for individuals, and perioperative BP should be tailored in an individual pattern. Futier et al. [73] pioneered individualized BP tailoring in 2017, and in their study, the eligible patients were randomly allocated into individualized BP management groups (systolic BP was controlled within 10% of the baseline value during surgery under the administration of norepinephrine) and conventional BP management group (ephedrine was injected when the systolic BP was less than 80 mmHg or was 40% 10 Oxidative Medicine and Cellular Longevity lower than the preoperative values). They observed that individualized BP management reduced the incidence of systemic inflammatory response syndrome; renal, cardiovascular, coagulation, or neurological impairment; or impairment of at least one vital organ system, compared to routine management [73]. However, this study did not evaluate the volume status objectively. Titration of vasoconstrictors to maintain individualized arterial pressure might cover the hypovolemic status, which would reduce end-organ blood flow and result in tissue hypoperfusion. Lately, individualized hemodynamic management requiring optimizing the volume simultaneously during individualized BP management was introduced into clinical practice [100]. Typically, this entails using a closed-loop autonomous system and incorporating machine learning (a subset of artificial intelligence) to control and predict BP variations during the operative period. In a randomized clinical trial on individualized hemodynamic management published in 2020, 188 high-risk patients undergoing major abdominal surgery were divided into a conventional management group and an individualized management group, which required anesthesiologists to use a proprietary algorithm, based on a noninvasive pulse wave analysis to guided intraoperative fluid infusion and/or dobutamine administration, thus maintaining the intraoperative cardiac index at the baseline values. The results showed that the individualized management group had a lower composite outcome of major postoperative complications or death within 30 days [97]. In 2021, Joosten et al. [101] developed a hybrid system including a computer-assisted closed-loop system for vasopressors and a decision-support system for bolus fluid challenge for intermediate to high-risk surgical patients. They observed that the prevalence of IOH in the computerassisted group was 1.2% and 21.5% in the individualized management group. This suggests that individualized hemodynamic optimization decreases the incidence of IOH and may be a potential BP management strategy.
Fundamentally, there are frequent serial fluctuations in cardiocirculatory parameters prior to hypotension. Hence, the development of a hypotension prediction index will help prevent hypotension. By analyzing BP waveform characteristics using machine deep learning algorithms, Hatib et al. [102] pioneered the prediction of hypotension occurrence with MAP values below 65 mmHg 1 min, 5 min, or even earlier, thus allowing clinicians to intervene during hypotension or even prevent hypotension. The algorithm was verified in 204 surgical patients. It showed that the sensitivity and specificity of predicting hypotension 15 min before the onset of hypotension were 88% and 87%, respectively. However, the algorithm was unable to predict hypotension due to clinical interventions, including intraoperative compression of large vessels or changes in position, such as the Trendelenburg position. Schneck et al. [103] found that the application of the algorithm conferred a significantly lower IOH incidence and a significantly shorter IOH duration than conventional BP management. However, in a single-center trial by Maheshwari et al. [104] involving 214 patients undergoing medium-and high-risk noncardiac surgery, the algorithm predicted hypotension but did not reduce the amount of IOH. The investigators concluded that the algorithm for treatment recommendations in the treatment algorithm system was too complex and needed further optimization to ensure timely clinical intervention. Based on this, considering the large proportion of low-risk patients who undergo conventional common surgery, we should weigh the riskbenefit ratio when using expensive noninvasive hemodynamic devices, as it is a valuable tool or a superfluous toy for the right patients [105]. Fully automated individualized hemodynamic management has broad prospects with advances in computer technology, especially in high-risk patients, as supported by recent studies [75,106,107].

Provisional Decision-Making and Targets in Practice
Given the dynamic nature of BP, perioperative individualized BP management is not to set a fixed threshold, but rather an individualized BP target value that considers the baseline BP, pathophysiology, comorbidities, perioperative agent use, and surgery.
In clinical practice, individualized BP targets can be achieved, which will ultimately improve patient outcomes through an easy and rapid process. The "5 Ts" (target patients, timing and type of intervention, target variables, and values) may provide a reference for rapid individualized BP management [108,109].
Targeting an appropriate BP is a challenge. Clinically, several factors should be considered when setting an appropriate BP target [110,111]: (1) hypotension does not always appear to be harmful and lead to organ hypoperfusion [112]; (2) the goal is to ensure sufficient perfusion pressure and oxygen delivery, not to correct a number [113]; (3) the pressure regulation ability and ischemia tolerability varies with organs [110,111]; (4) an absolute threshold is easy to use and often adopted in decision-making; (5) intravascular volume status is fundamental and essential for organ perfusion and should be evaluated simultaneously when correcting hypotension [114,115]; (6) specific pathophysiology alterations of the surgical patient (e.g., shock, hemorrhage, and sepsis); (7) the BP requirements for high-risk elderly patients undergoing major surgery is quite different from those of normal patients undergoing a brief surgery; (8) strict BP management is more conducive for the protection of organ functions than laissez-faire or lenient BP management [116]; (9) a "one-size-fits-all" approach should be abandoned and personalized BP targets that vary with time should be adopted; and (10) a holistic attitude when treating refractory hypotension should be adopted.
BP targets vary with the population characteristics and surgical type. The patient's baseline BP measurements are a major determinant for perioperative BP targets. Based on the BP values, the baseline BP can be classified into three categories: the low (systolic BP < 90 mmHg and diastolic BP < 50 mmHg), normal (systolic BP 90-139 mmHg and diastolic BP 50-89 mmHg), and high baseline BP (systolic BP ≥ 140 mmHg and diastolic BP ≥ 90 mmHg) categories. The BP target for patients with a low baseline BP undergoing noncardiac surgery should be maintained at a MAP ≥ 60 mmHg based on results of multiple studies [52,[55][56][57]64] and a MAP > 65 mmHg for patients with a normal BP [30,50,73,117]. BP should be maintained within 80%-110% of the baseline BP in patients with a high base-line BP [30,52,73,118,119] and at a systolic BP of ≤160 mmHg [63,120], which is favorable for the outcomes. For cardiac surgery, the requirements for BP during and before or after extracorporeal circulation are different. Before and after extracorporeal circulation, the target BP may be the optimal value for patients undergoing noncardiac surgery: the intraoperative systolic BP should not be higher than 140 mmHg [50,121], and the MAP should be kept at 70-100 mmHg during cardiopulmonary bypass [70,71,122,123]. BP targets for patients with specific pathophysiological alterations should be tailored in an individualized manner. In a perioperative setting, two conditions are often encountered: the BP targets and management of hypotension. The pragmatic decision-making flow chart is depicted in Figure 2.
For postoperative BP, maintaining a systolic BP of 90-160 mmHg is a reasonable target for patients with a normal baseline BP. However, for patients with an abnormal baseline BP, these targets should be adjusted according to the preoperative baseline values [84].

Conclusion and Perspectives
BP can be corrected, and hypotension should be avoided. Given the nature of BP, perioperative BP management is a dynamic process and not a fixed point. From existing evidence, maintaining the MAP of normal patients at ≥65 mmHg perioperatively is widely accepted, MAP value at 65 mmHg can be considered a minimum level for BP management and adjustment and at the same time not solely concentrates on the value but tailors individually suffice for organ blood supply.
Both IOH and POH have detrimental effects on patient prognosis, and there is paucity of evidence on the direct relationship between hypotension and adverse outcomes, and an absolute BP target is usually selected as the initial target for perioperative BP management. The baseline BP is helpful for setting an appropriate BP target, and personalized BP targets may change over time owing to abrupt pathophysiological alterations perioperatively. Strict BP management relying on baseline BP and maintaining fluctuations within ±20% or ±10% of the baseline BP is an optimal BP control method. Further research is needed to define individual BP harm thresholds and to develop therapeutic strategies to treat and avoid IOH.
The newly emerged hypotension prediction index algorithm and automated BP control system are helpful for individualized hemodynamic management, especially for highrisk patients. It is necessary to validate whether the machine learning algorithm or artificial intelligence-based intervention for BP management is valuable for all patients, especially for high-risk patients.

Conflicts of Interest
The authors declare that there is no conflict of interest regarding the publication of this paper. 12 Oxidative Medicine and Cellular Longevity